Home | Welcome to Contract Pharma   
Last Updated Sunday, December 21 2014

Print RSS Feed

Breaking News

Related Searches: Preclinical Testing CRO Stability Testing
Gil Roth
June 28, 2011
New facility will support drug product, biologics manufacturing  Read More »
Gil Roth
June 28, 2011
Three-year deal will focus on neuroscience candidates  Read More »
Gil Roth
June 28, 2011
Will run Phase II-IV business in region  Read More »
Gil Roth
June 27, 2011
Preclinical CRO begins construction on expanded Efficacy and Ssurgical Research Services wing  Read More »
Gil Roth
June 27, 2011
Submission-ready documentation now provided through Regulatory Services Group  Read More »
Gil Roth
June 27, 2011
Discover collaboration began in April 2009 for molecules targeting CV, CNS, urology   Read More »
Gil Roth
June 27, 2011
Co-founder Hinchen to succeed Peter Jenkins  Read More »
Gil Roth
June 24, 2011
RCB to use maxXpress to help develop fusion protein for autoimmune indications  Read More »
Gil Roth
June 24, 2011
Three-year deal covers development-stage cancer drugs, may lead to companion diagnostics  Read More »
Gil Roth
June 24, 2011
State-of-the-art site, validated in 2009, will initially be used for Phase III supplies  Read More »
Gil Roth
June 24, 2011
Second complete response letter for ER oxycodone  Read More »
June 24, 2011
Reed-Lane has redesigned its website.  Read More »
June 23, 2011
Octagon Research Solutions, Inc. is expanding globally by adding 100 clinical and regulatory professionals, and expanding its U.S. headquarters, and opening new facilities in the UK and India.  Read More »
June 23, 2011
Neuland Laboratories Ltd. has expanded its manufacturing capabilities for synthetic peptides.   Read More »
June 23, 2011
Jubilant Biosys Ltd., a subsidiary of Jubilant Life Sciences Ltd., has successfully completed an early stage milestone in its neuroscience collaboration with AstraZeneca in the pain therapeutic area.  Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On